Pre-term Birth

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

H
HologicMA - Marlborough
1 program
fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm BirthN/A1 trial
Active Trials
NCT01955148Unknown1,210Est. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HologicfFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Clinical Trials (1)

Total enrollment: 1,210 patients across 1 trials

NCT01955148HologicfFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Start: Oct 2013Est. completion: Sep 20161,210 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space